Alto Neuroscience, Inc. (ANRO) Stock Forecast & Price Target

Compare

460 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ANRO Analyst Ratings

Strong Buy

6 Buy

1 Hold

0 Sell

Based on 7 analysts giving stock ratings to

Alto

Neuroscience, Inc.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ANRO Stock 12 Month Forecast

Average Price Target

$10.40

▲(300.00%Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Alto Neuroscience, Inc. in the last 3 months. The average price target is $10.40 with a high forecast of $15.00 and a low forecast of $4.00. The average price target represents a 300.00% change from the last price of $2.60.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","5":"$5","9":"$9","13":"$13","17":"$17"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$10.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,5,9,13,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.6,3.553846153846154,4.507692307692308,5.461538461538462,6.415384615384616,7.36923076923077,8.323076923076924,9.276923076923078,10.230769230769232,11.184615384615384,12.138461538461538,13.092307692307692,14.046153846153846,{"y":15,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.6,3.2,3.8000000000000003,4.4,5,5.6000000000000005,6.200000000000001,6.800000000000001,7.4,8,8.600000000000001,9.200000000000001,9.8,{"y":10.4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.6,2.707692307692308,2.8153846153846156,2.9230769230769234,3.0307692307692307,3.1384615384615384,3.246153846153846,3.353846153846154,3.4615384615384617,3.569230769230769,3.676923076923077,3.7846153846153845,3.8923076923076922,{"y":4,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.1,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.96,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.4,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.81,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.81,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.17,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.98,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.38,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.29,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.8,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.02,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.45,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.6,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$15.00

Average Price Target$10.40

Lowest Price Target$4.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ritu BaralTD Cowen

TD Cowen

―

Buy

―

Reiterated

06/30/25

Analysts Are Bullish on Top NA Stocks: Alto Neuroscience, Inc. (ANRO), Rapport Therapeutics, Inc. (RAPP)

Paul MatteisStifel Nicolaus

Stifel Nicolaus

$10

Buy

284.62%

Upside

Reiterated

06/30/25

Patrick TrucchioH.C. Wainwright

H.C. Wainwright

$10

Buy

284.62%

Upside

Reiterated

06/30/25

H.C. Wainwright Reaffirms Their Buy Rating on Alto Neuroscience, Inc. (ANRO)

Laura ChicoWedbush

Wedbush

Hold

53.85%

Upside

Reiterated

06/27/25

Wedbush Remains a Hold on Alto Neuroscience, Inc. (ANRO)

Justin WalshJonesTrading

JonesTrading

$18→$13

Buy

400.00%

Upside

Reiterated

06/27/25

JonesTrading Reaffirms Their Buy Rating on Alto Neuroscience, Inc. (ANRO)

Myles MinterWilliam Blair

William Blair

―

Buy

―

Reiterated

06/26/25

Optimistic Buy Rating for Alto Neuroscience Amid Promising ALTO-203 Developments and Strategic Opportunities

Andrew TsaiJefferies

Jefferies

$15

Buy

476.92%

Upside

Reiterated

06/09/25

Promising Future for Alto Neuroscience: Strategic Acquisition and Strong Financial Position Drive Buy Rating

Brian SkorneyRobert W. Baird

Robert W. Baird

$10

Buy

284.62%

Upside

Reiterated

11/12/24

Potential Catalysts and Strategic Focus: Analyzing Alto Neuroscience's Upcoming Trials and Precision Psychiatry Approach

Elemer PirosLucid Capital

Lucid Capital

$5.5

Hold

111.54%

Upside

Downgraded

10/23/24

Alto Neuroscience downgraded to Neutral from Buy at Rodman & RenshawAlto Neuroscience downgraded to Neutral from Buy at Rodman & Renshaw

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ritu BaralTD Cowen

TD Cowen

―

Buy

―

Reiterated

06/30/25

Analysts Are Bullish on Top NA Stocks: Alto Neuroscience, Inc. (ANRO), Rapport Therapeutics, Inc. (RAPP)

Paul MatteisStifel Nicolaus

Stifel Nicolaus

$10

Buy

284.62%

Upside

Reiterated

06/30/25

Patrick TrucchioH.C. Wainwright

H.C. Wainwright

$10

Buy

284.62%

Upside

Reiterated

06/30/25

H.C. Wainwright Reaffirms Their Buy Rating on Alto Neuroscience, Inc. (ANRO)

Laura ChicoWedbush

Wedbush

Hold

53.85%

Upside

Reiterated

06/27/25

Wedbush Remains a Hold on Alto Neuroscience, Inc. (ANRO)

Justin WalshJonesTrading

JonesTrading

$18→$13

Buy

400.00%

Upside

Reiterated

06/27/25

JonesTrading Reaffirms Their Buy Rating on Alto Neuroscience, Inc. (ANRO)

Myles MinterWilliam Blair

William Blair

―

Buy

―

Reiterated

06/26/25

Optimistic Buy Rating for Alto Neuroscience Amid Promising ALTO-203 Developments and Strategic Opportunities

Andrew TsaiJefferies

Jefferies

$15

Buy

476.92%

Upside

Reiterated

06/09/25

Promising Future for Alto Neuroscience: Strategic Acquisition and Strong Financial Position Drive Buy Rating

Brian SkorneyRobert W. Baird

Robert W. Baird

$10

Buy

284.62%

Upside

Reiterated

11/12/24

Potential Catalysts and Strategic Focus: Analyzing Alto Neuroscience's Upcoming Trials and Precision Psychiatry Approach

Elemer PirosLucid Capital

Lucid Capital

$5.5

Hold

111.54%

Upside

Downgraded

10/23/24

Alto Neuroscience downgraded to Neutral from Buy at Rodman & RenshawAlto Neuroscience downgraded to Neutral from Buy at Rodman & Renshaw

Stocks with the Highest Top Analyst Consensus in the General Sector

xxx

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alto Neuroscience, Inc.

1 Month

xxx

Success Rate

4/8 ratings generated profit

Average Return

-6.73%

reiterated a xxx

rating 8 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -6.73% per trade.

3 Months

xxx

Success Rate

2/12 ratings generated profit

Average Return

-28.50%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 16.67% of your transactions generating a profit, with an average return of -28.50% per trade.

1 Year

Ritu BaralTD Cowen

Success Rate

2/12 ratings generated profit

Average Return

-46.43%

reiterated a buy rating 13 days ago

Copying Ritu Baral's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -46.43% per trade.

2 Years

xxx

Success Rate

2/12 ratings generated profit

Average Return

-46.39%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -46.39% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ANRO Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ANRO has received 17 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ANRO average Analyst price target in the past 3 months is 10.40.

Each month's total comprises the sum of three months' worth of ratings.

ANRO Financial Forecast

ANRO Earnings Forecast

Next quarter’s earnings estimate for ANRO is -$0.60 with a range of -$0.79 to -$0.50. The previous quarter’s EPS was -$0.56. ANRO beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 100.00% of the time in the same period. In the last calendar year ANRO has Outperformed its overall industry.

No data currently available

ANRO Sales Forecast

Next quarter’s sales forecast for ANRO is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ANRO beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 0.00% of the time in the same period. In the last calendar year ANRO has Preformed in-line its overall industry.

ANRO Stock Forecast FAQ

What is ANRO’s average 12-month price target, according to analysts?

Based on analyst ratings, Alto Neuroscience, Inc.’s 12-month average price target is 10.40.

What is ANRO’s upside potential, based on the analysts’ average price target?

Alto Neuroscience, Inc. has 300.00% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ANRO a Buy, Sell or Hold?

Alto Neuroscience, Inc. has a consensus rating of Strong Buy which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.

What is Alto Neuroscience, Inc.’s price target?

The average price target for Alto Neuroscience, Inc. is 10.40. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $15.00 ,the lowest forecast is $4.00. The average price target represents 300.00% Increase from the current price of $2.6.

What do analysts say about Alto Neuroscience, Inc.?

Alto Neuroscience, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of ANRO?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Alto Neuroscience, Inc. (ANRO) Stock Forecast & Price Target

ANRO Analyst Ratings

ANRO Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Alto Neuroscience, Inc.

ANRO Analyst Recommendation Trends

ANRO Financial Forecast

ANRO Earnings Forecast

ANRO Sales Forecast

ANRO Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts